| Literature DB >> 36056186 |
Dong Kyu Kim1,2, Hyobin Jeong3,4, Jingi Bae5, Moon-Yong Cha6, Moonkyung Kang7, Dongjin Shin1, Shinwon Ha8, Seung Jae Hyeon9, Hokeun Kim5, Kyujin Suh1,2, Mi-Sun Choi10, Hoon Ryu9, Seong-Woon Yu8, Jong-Il Kim1,11, Yeon-Soo Kim7, Sang-Won Lee12, Daehee Hwang13, Inhee Mook-Jung14,15.
Abstract
Mitochondria in neural progenitors play a crucial role in adult hippocampal neurogenesis by being involved in fate decisions for differentiation. However, the molecular mechanisms by which mitochondria are related to the genetic regulation of neuronal differentiation in neural progenitors are poorly understood. Here, we show that mitochondrial dysfunction induced by amyloid-beta (Aβ) in neural progenitors inhibits neuronal differentiation but has no effect on the neural progenitor stage. In line with the phenotypes shown in Alzheimer's disease (AD) model mice, Aβ-induced mitochondrial damage in neural progenitors results in deficits in adult hippocampal neurogenesis and cognitive function. Based on hippocampal proteome changes after mitochondrial damage in neural progenitors identified through proteomic analysis, we found that lysine demethylase 5A (KDM5A) in neural progenitors epigenetically suppresses differentiation in response to mitochondrial damage. Mitochondrial damage characteristically causes KDM5A degradation in neural progenitors. Since KDM5A also binds to and activates neuronal genes involved in the early stage of differentiation, functional inhibition of KDM5A consequently inhibits adult hippocampal neurogenesis. We suggest that mitochondria in neural progenitors serve as the checkpoint for neuronal differentiation via KDM5A. Our findings not only reveal a cell-type-specific role of mitochondria but also suggest a new role of KDM5A in neural progenitors as a mediator of retrograde signaling from mitochondria to the nucleus, reflecting the mitochondrial status.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36056186 PMCID: PMC9534996 DOI: 10.1038/s12276-022-00841-w
Source DB: PubMed Journal: Exp Mol Med ISSN: 1226-3613 Impact factor: 12.153